Find your path to Rob
Sign up to see every warm intro you have to Rob
- Paths you didn't know you had: your email and LinkedIn already hold routes to Rob. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
A partner in Hoxton Ventures' first three funds, Rob is American-born with a technical background, having studied Computer Science at Maryland and Management Science & Engineering at Stanford. He previously worked at Intel, Google, and Fidelity's investment team, and has a particular interest in the biotech sector's growing use of computation.
Contact· self-published, not guessed
Likely emails· guessed from name + firm domain, not firm-published
- r•••@hoxtonventures.comreveal90% confident
- r•••@hoxtonventures.comreveal75% confident
Invests in
AI & Machine LearningBiotech
Deals · 2
PharmaccxBoard seat
via Hoxton Ventures · filed Jul 2023 · $5.4M raise
OUROTECH, INC.- PEAR BIOBoard seat
via Hoxton Ventures · filed Apr 2023 · $16.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AssetarioBabylon HealthBoost SecurityBotherCampanjaCCXDeblockFabricnanoFlair ImpactImmunioKheiron MedicalLimbo RevolutionMainframeMavrxMultiomic HealthNoMagicOrdercastPear BioPhagosValink Therapeutics
Investor
BabylonBotherCampanjaDeblockDeliverooFabricnanoFlair ImpactImmunioInovivKheironLimboLLUSTREMainframeMavrxMultiomic HealthNomagicOchre BioOptimoRoutePhagosPreplyRaptor SuppliesSpaceliftSuperawesomeValink TherapeuticsVatic Health
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Hoxton Ventures
Network3
Investors connected to Rob in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Rob Kniaz?
- A partner in Hoxton Ventures' first three funds, Rob is American-born with a technical background, having studied Computer Science at Maryland and Management Science & Engineering at Stanford. He previously worked at Intel, Google, and Fidelity's investment team, and has a particular interest in the biotech sector's growing use of computation.
- Where does Rob Kniaz work?
- Rob Kniaz is Partner Emeritus at Hoxton Ventures.
- What does Rob Kniaz invest in?
- Rob Kniaz invests in AI & Machine Learning, Biotech.
- What check size does Rob Kniaz write?
- Rob Kniaz typically writes checks of $500K – $5M.
- What boards does Rob Kniaz sit on?
- Rob Kniaz holds tracked board seats at Assetario, Babylon Health, Boost Security, Bother, Campanja, CCX, Deblock, Fabricnano, Flair Impact, Immunio.
- What companies has Rob Kniaz invested in?
- Investments tracked here include Babylon, Bother, Campanja, Deblock, Deliveroo, Fabricnano, Flair Impact, Immunio, Inoviv, Kheiron, Limbo, LLUSTRE, and 13 more.
About this profile. Compiled from public sources — Hoxton Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights












